COVID-19 Vaccine Could Cost As Little As $10 A Dose, Says Janssen

Full Global Access Not Expected Until Late 2021

Non-profit approach is reassuring for healthcare payers, but vaccines won’t be ready to stop pandemic at its peak.

Stoffels_Paul
J&J's chief scientific officer Paul Stoffels • Source: J&J

More from Business

More from Scrip